Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors - Results from the Baltimore Longitudinal Study on Aging

被引:124
作者
Blake, DR
Meigs, JB
Muller, DC
Najjar, SS
Andres, R
Nathan, DM
机构
[1] Massachusetts Gen Hosp, Diabet Unit, Ctr Diabet, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Boston, MA 02114 USA
[4] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA
[5] NIA, Baltimore, MD 21224 USA
关键词
D O I
10.2337/diabetes.53.8.2095
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) identify individuals at high risk for progression to diabetes. Whether IFG and IGT have comparable coronary heart disease (CHD) risk factor profiles, independent of their progression to diabetes, is unclear. We determined CHD risk factor levels in 937 nondiabetic individuals at baseline and biannually over a mean follow-up period of 9.6 years. Subjects had no known CHD at baseline and had greater than or equal to 2 (mean 4.2) oral glucose tolerance tests during follow-up. We classified glucose tolerance categories using American Diabetes Association diagnostic criteria or modified criteria that redefined IFG as 100-126 mg/dl, creating a similar baseline prevalence of IFG and IGT. Subjects who developed diabetes during follow-up were excluded from our analysis. Baseline CHD risk factors were similar in subjects with normal glucose tolerance (NGT) and IFG, but significantly more atherogenic in those with IGT or IFG + IGT. These findings were unchanged when the modified criteria were used, suggesting that IGT is phenotypically different from IFG and is associated with increased levels of CHD risk factors. Subjects with isolated IFG had similar levels of CHD risk factors as NGT subjects, even when IFG was redefined with a lower threshold. Although CHD risk factors were increased in the IGT group, the incidence of CHD events was not significantly different among groups, perhaps owing to the limited number of events. The differences in CHD risk factors among prediabetic groups may have clinical implications for screening strategies and CHD risk stratification of individuals with IFG and IGT.
引用
收藏
页码:2095 / 2100
页数:6
相关论文
共 25 条
[1]  
American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5
[2]  
[Anonymous], [No title captured]
[3]   High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men -: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study [J].
Balkau, B ;
Shipley, M ;
Jarrett, RJ ;
Pyörälä, K ;
Pyörälä, M ;
Forhan, A ;
Eschwège, E .
DIABETES CARE, 1998, 21 (03) :360-367
[4]   The relationship between glucose and incident cardiovascular events [J].
Coutinho, M ;
Gerstein, HC ;
Wang, Y ;
Yusuf, S .
DIABETES CARE, 1999, 22 (02) :233-240
[5]   C-reactive protein is more strongly related to post-glucose load glucose than to fasting glucose in non-diabetic subjects; the Insulin Resistance Atherosclerosis Study [J].
Festa, A ;
D'Agostino, R ;
Tracy, RP ;
Haffner, SM .
DIABETIC MEDICINE, 2002, 19 (11) :939-943
[6]   Body mass index, diabetes, and C-reactive protein among US adults [J].
Ford, ES .
DIABETES CARE, 1999, 22 (12) :1971-1977
[7]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[8]  
Gavin JR, 1997, DIABETES CARE, V20, P1183
[9]   Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals [J].
Hanefeld, M ;
Koehler, C ;
Schaper, F ;
Fuecker, K ;
Henkel, E ;
Temelkova-Kurktschiev, T .
ATHEROSCLEROSIS, 1999, 144 (01) :229-235
[10]   Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose - The risk factor in impaired glucose tolerance for atherosclerosis and diabetes study [J].
Hanefeld, M ;
Koehler, C ;
Fuecker, K ;
Henkel, E ;
Schaper, F ;
Temelkova-Kurktschiev, T .
DIABETES CARE, 2003, 26 (03) :868-874